Term
EPINEPHRINE
Drug Name/Trade Name/Class |
|
Definition
Drug Name: Epinephrine
Trade Name: Adrenaline, Epi
Class:
-Adrenergic Catecholamine
-Sympathomimetic
|
|
|
Term
EPINEPHRINE
Mechanism of Action |
|
Definition
Beta 1:--contractility, inotropic, increases AV conduction, automaticity
Beta 2:--bronchodilation, skeletal muscle vasodilation
Alpha:--peripheral vasoconstriciton, fight/flight response
Small doses (slow administration), beta effects dominate--vasodilation
Large doses (rapid administration), alpha effect dominate--vasoconstriction, increases systemic vascular resistance, blood pressure
- CNS Stimulation |
|
|
Term
EPINEPHRINE
Indications (6)
|
|
Definition
Indications:
- Hypersensitivity Reactions (anaphylaxis)
- Acute bronchospasm associated w/ asthma or COPD (refractory to first-line agents)
- Asystole, VF, pulseless VT, PEA
- Symptomatic Bradycardia
- Refractory hypotensions
- Croup & Epiglottitis |
|
|
Term
EPINEPHRINE
Contraindications (2) & Precautions (9)
|
|
Definition
Contraindications:
- None in cardiac arrest or severe anaphylaxis
- Hypersensitivity
Precautions:
- Will increases myocardial osygen demand
- HTN
- Ischemic Heart disease
- Cerebrovascular insufficiency
- Pulmonary Edema
- Pregnancy Class (c)
- Geriatrics
- Protect from light
- Deactivated by alkaline solutions (NaHCO3)
|
|
|
Term
EPINEPHRINE
Available Forms |
|
Definition
1) 1:1000 1 mg/mL (amps, vials, pre-filled syringes, 30 mL vials)
2) 1:10000 0.1 mg/mL (10 mL pre-filled syringe) |
|
|
Term
EPINEPHRINE
Adult Dosages |
|
Definition
Anaphylaxis: 0.3-0.5 mg SubQ/IM (1:1000) every 5-15 mins. PRN
- Infusion: 1 mg (1:1000)/100 cc via Buretrol -OR-1 mg (1:1000)/ 250 cc
administered at a rate of 2-10 mcg/min.; titrated to response
Nebulizer (laryngeal edema): 5 mg (5cc) (1:1000) undiluted
Acute Broncospams0.3-0.5 mg (1:1000) SubQ/IM
Symptomatic Bradycardia & Refractory Hypotension:
Infusion-1 mg(1:1000)/100cc via Buretrol-OR-1 mg (1:10000)/ 250cc
administered at a rate of 2-10 mcg/min, titrated to response
Asystole, VF, pulseless VT, PEA:
Standard = 1 mg (1:10000) IV/IO every 3-5 mins.
ET: 2-2.5 X IV dose (diluted to a volume of 10 cc) every 3-5 mins.
|
|
|
Term
EPINEPHRINE
Pediatric Dosages |
|
Definition
CARDIAC ARREST: 0.01 mg/kg (1:10000) IV/IO every 3-5 min.
0.1 mg/kg (1:1000), diluted to a volume of 3-5 cc ET every 3-5 min.
SYMPTOMATIC BRADYCARDIA:
0.01 mg/kg (1:10000) IV/IO every 3-5 minutes
0.1 mg/kg (1:1000, diluted to a volume of 3-5 cc) ET every 3-5 min.
Infusion: 0.1-1 mcg/kg/min (1mg (1:1000)/250 NS=4 mcg/mL)-for persistent hypotension; titrate to response
ANAPHYLAXIS: 0.01 mg/kg (1:1000) SubQ/IM. Max 0.3 mg
Infusion - see symptomatic bradycardia
CROUP & EPIGLOTTITIS: 5 mg (5cc) of 1:1000 nebulized
BRONCHOSPAMS (severe refractory): 0.01 mg/kg (1:1000) SubQ/IM |
|
|
Term
EPINEPHRINE
Onset, Duration, Side Effects (11) |
|
Definition
ONSET:IV: 1-2 minutes, SC: 5-10 minutes
DURATION: IV/SC: 5-10 minutes
SIDE EFFECTS:
-Anxiety - Fear
-Tachy - Headache
-HTN - Pallor
-Angina - Dizziness
-Dysrhythmias - Tremors
-N/V
|
|
|
Term
|
Definition
Potentiated by: MAOI's, TCA's
Antagonized by: Beta blockers
Precipitates in Alkaline solutions |
|
|
Term
EPINEPHRINE
PEARLS of wisdom... |
|
Definition
- Sodium Bicarbonate & Furosemide will inactivate epi, flush line well between administration
- Although epi can by delivered ET, studies suggest that the ET route is less successful in arrest situation than IV. ET administration should be utilized only until IV or IO access can be established
- Because of epi's effects on myocardial O2 demand, pt.'s should be adequately oxygenated when receiving epi
- Epi (1:1000) should not be administered IV without dilution
|
|
|
Term
DOPAMINE HYDROCHLORIDE
Drug name, Trade name, Class |
|
Definition
Drug name: Dopamine Hydrochloride
Trade name: Dopamine; Intropin
Class:
- Adrenergic Dopaminergic Catecholamine
- Sympathomimetic |
|
|
Term
DOPAMINE
Mechanism of Action |
|
Definition
Naturally occuring catecholamine.
- 2-10 mcg/kg/min--beta receptors--inotropic,chronotropic
- 10-20 mcg/kg/min--alpha&beta--casoconstriction of renal, mesenteric, an dperipheral arteries and veins
- 20 mcg/kg/min +--alpha dominates, norepinephrine like effects |
|
|
Term
DOPAMINE
Indications (4), Contraindications (5), Precautions (4) |
|
Definition
Indications: Contraindications:
- Cardiogenic Shock - Women on oxytocin
- Neurogenic Shock - Tachydysrhythmias
- Septic Shock - VF/VT
- Refractory Bradycardia - Uncorrected hypovolemia
- Pt.'s w/ known pheochromocytoma
Precautions:
- MAOI's, TCA's, other cardiac stimulants, vasopressors, will cause increased HR, SV dysrhythmias
- Will ppt in basic, alkaline solutions
- May cause necrosis, sloughing at infusion site
- Pregnancy (c)
|
|
|
Term
DOPAMINE
Available Forms (4) |
|
Definition
- 40 mg/mL -- 200 mg/5mL (amps vials)
- 80mg/100mL -- 0.8mg/mL (200mg in 250mL D5W)
- 160mg/100mL--1.6mg/mL (400mg in 250mL D5W)
- 320mg/100mL--3.2 mg/mL (800mg in 250mL D5W)
|
|
|
Term
|
Definition
2-20 mcg/kg/min
titrate to effect, running through a lrg. vein.
adding 2 vials (400 mg) to 250mL of NS = 1600 mcg/mL |
|
|
Term
DOPAMINE
Pediatric dosage |
|
Definition
2-20 mcg/kg/min - titrated to effect
-multiply by childs weight X6 & dilute to a total volume of 100 mL
- when the resulting mix is administered at 1mL/hr; it delivers a dose of 1 mcg/kg/min. |
|
|
Term
DOPAMINE
Onset, Duration, and Interactions (4) |
|
Definition
Onset: 2-4 minutes
Duration: 10-15 minutes
Interactions:
-potentiated by MAOI's/TCA's, bretylium
-ppt in alkaline solutions
- discard if pink or brown
- may cause hypotension when used concomitantly with phenytoin (dilantin) |
|
|
Term
DOPAMINE
Side Affects (10) |
|
Definition
1.) Dysrhythmias 7.) Angina/AMI
2.) HTN/HA 8.) Pain
3.) N/V 9.) Tachycardia
4.) Dizziness 10.) Bradycardia
5.) Tremors
6.) Flushing |
|
|
Term
|
Definition
- Can cause tissue necrosis and sloughing. take care to avoid infiltration, use control IV access or lrg. veins of the arm
-Titrate dosage to pt.'s hemodynamic response |
|
|
Term
VASOPRESSIN, ADH
Drug Name, Trade Name, Class |
|
Definition
Drug Name:
Vasopressin, ADH
Trade Name:
Pitressin
Class:
Exogenous, parenteral form of ADH |
|
|
Term
VASOPRESSIN, ADH
Mechanism of Action (4)
|
|
Definition
1.) In unnaturally high doses, vasopressin acts as an non-adrenergic peripheral vasoconstrictor
2.) Vasopressin acts by direct stimulation of smooth muscle V1 receptors, causing intense peripheral vasoconstriction of skin, skeletal muscle, intestine, & fat with less constriction of coronary and renal vascular beds.
3.) Vasopressin produces no skeletal muscle vasodilation of incresed myocardial oxygen demand during CPR because it has no beta-adrenergic activity
4.) In one study, after a short duration of ventricular fibrillation & during CPR, vasopressin increased coronary perfusion pressure, vital organ blood flow, and cerebral oxygen deliver
|
|
|
Term
VASOPRESSIN
Indications (1), Contraindications (1), Precautions (6) |
|
Definition
Indications: Adult refractory pulseless arrest
Contraindications: None
Precautions: few if any in arrest settings
- Migraine
- Epilepsy
- CHF
- Asthma
- CAD
- Pregnancy (C) |
|
|
Term
VASOPRESSIN
Available Forms, Dosage (adults), Onset, Duration |
|
Definition
Available Forms: 5 U/mL
Dosage (adults only): IV - single dose of 40 U
Onset: immediate
Duration: variable |
|
|
Term
VASOPRESSIN
Side Effects (6)
|
|
Definition
possible post-resuscitation - Ischemic CP
- ABD distress
- N/V
- Sweating
- Tremors
- Bronchial constriction
|
|
|
Term
VASOPRESSIN
Interactions & PEARLS.. |
|
Definition
Interactions: None
PEARLS: may be used to replace the 1st of 2nd dose of epi in pulselss arrest |
|
|